Skip to search.
 TSX Up 0.65% TSX Ventures Up 0.34%

Incyte Corporation (INCY)

-NasdaqGS
102.35 Down 4.86(4.53%) 3:16PM EST - Nasdaq Real Time Price
Prev Close:107.21
Open:104.76
Bid:102.52 x 100
Ask:102.68 x 200
1y Target Est:109.14
Beta:1.23427
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:99.72 - 106.53
52wk Range:55.00 - 118.49
Volume:1,577,085
Avg Vol (3m):1,445,740
Market Cap:19.28B
P/E (ttm):137.57
EPS (ttm):0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 4.53%19.28B
1 0.00%N/A
CELGDown 4.16%87.22B
AMGNDown 2.89%104.83B

Key Statistics

Forward P/E (1 yr):71.22
P/S (ttm):19,740.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.59
Quarterly EPS Est (Dec-16) :0.13
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback